Department of Pediatric Critical Care, University of Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France.
French National Out-of-Hospital Cardiac Arrest Registry Research Group - Registre électronique des Arrêts Cardiaques, Lille, France.
Pediatr Crit Care Med. 2021 Mar 1;22(3):286-296. doi: 10.1097/PCC.0000000000002659.
Despite the evolving recommendations that favor the use of intraosseous access in pediatric resuscitation, the impact of vascular access type on survival in young children has not been demonstrated. The aim of this study was to assess the impact of the intravascular injection route on the return on spontaneous circulation, survival to hospital admission (0 day), and 30 days or survival to hospital discharge, by comparing survival rates in young children having intraosseous and peripheral IV access. The second aim was to compare the rates of favorable neurologic outcome after 30 days or survival to hospital discharge.
This was a multicenter retrospective comparative study between July 2011 and October 2018.
Based on the French cardiac arrest registry data.
All prepubescent (males < 12 yr old, females < 10 yr old) victims of an out-of-hospital cardiac arrest.
Patients with adrenaline administration by intraosseous versus peripheral venous technique were compared, using propensity score matching.
The analysis included 603 prepubescent patients, 351 (58%) in the intraosseous group and 252 (42%) in the peripheral IV group. Intraosseous group patients were younger, lighter, with more medical cause for arrest. The intraosseous group had lower survival rates at 30 days or hospital discharge (n = 6; 1.7%) than the peripheral IV group (n = 12; 4.8%) (p = 0.030). After matching, 101 pairs of patients were created. No difference was observed on return of spontaneous circulation or 0-day survival rates (odds ratio = 1.000 [95% CI, 0.518-1.930]; odds ratio = 0.946 [95% CI, 0.492-1.817], respectively) and on 30 days or hospital discharge survival (n = 3 in both groups) (odds ratio = 1.000 [95% CI, 0.197-5.076]). Meaningful statistical evaluation of neurologic status among survivors was precluded by inadequate numbers.
The type of injection route (intraosseous or peripheral venous access) does not appear to have an impact on survival of out-of-hospital cardiac arrest in a prepubescent population, but limitations of propensity matching limit a definitive conclusion.
尽管不断有研究建议在儿科复苏中优先使用骨内通路,但血管内注射途径对幼儿存活率的影响尚未得到证实。本研究旨在通过比较骨内通路和外周静脉通路患儿的自主循环恢复率、入院时(0 天)存活率和 30 天或出院存活率,评估血管内注射途径对自主循环恢复率、入院时(0 天)存活率和 30 天或出院存活率的影响。第二项目的是比较 30 天或出院后神经系统结局良好的发生率。
这是一项 2011 年 7 月至 2018 年 10 月期间的多中心回顾性比较研究。
基于法国心脏骤停登记数据。
所有非院内心脏骤停的青春期前(男性<12 岁,女性<10 岁)患儿。
使用倾向评分匹配比较肾上腺素经骨内与外周静脉给药的患儿。
共纳入 603 例青春期前患儿,其中 351 例(58%)接受骨内注射,252 例(42%)接受外周静脉注射。骨内组患儿年龄更小、体重更轻,且因医疗原因导致心脏骤停的比例更高。骨内组患儿 30 天或出院时的存活率(n=6;1.7%)低于外周静脉组(n=12;4.8%)(p=0.030)。匹配后,共创建了 101 对患儿。两组患儿的自主循环恢复率或 0 天存活率(比值比=1.000[95%可信区间,0.518-1.930];比值比=0.946[95%可信区间,0.492-1.817])以及 30 天或出院时的存活率(n=两组各 3 例)(比值比=1.000[95%可信区间,0.197-5.076])均无差异。由于幸存者的神经状态评估数量不足,无法进行有意义的统计学评估。
在青春期前人群中,注射途径(骨内或外周静脉通路)似乎不会影响院外心脏骤停的存活率,但倾向评分匹配的局限性限制了明确结论的得出。